To address the mechanisms of DAB 2 downregulation during colitis, we generated BMDCs in vitro using FLT3L and GM-CSF, a protocol capable of inducing a more heterogeneous mix of DCs based on their CD103 and CD11b expression (35) (Figure 3A). The gene discussed is ITGAM; the disease is colitis.